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INTRODUCTION
Hypoglycemic episodes developing during nocturnal sleep represent a major problem in type 1 diabetes (1). Patients with type 1 diabetes frequently fail to awake during nighttime hypoglycemia (2, 3) . Also, sleep distinctly reduces neuroendocrine counterregulation to hypoglycemia (4, 5) . So far, studies investigating counterregulatory responses to experimentally-induced nocturnal hypoglycemia have focused exclusively on the early part of nocturnal sleep (2) (3) (4) . However, early and late nocturnal sleep shows striking differences in their sleep architecture. Whereas early sleep is dominated by slow wave sleep (SWS), i.e., non-REM sleep stage 3 and 4 (REMrapid eye movement), in the late part of sleep REM sleep prevails. Notably, the brain's demand for glucose during SWS is overall reduced to a minimum, and distinctly lower than in the wake state or during REM sleep (6, 7) . It could well be that the reduced hypoglycemia counterregulation during sleep observed in previous studies results from lowered central nervous demands of glucose that are particularly low during SWS. Along with the marked differences in sleep stages, secretory activity of most neuroendocrine systems involved in hypoglycemic counterregulation show likewise characteristic temporal dynamics across nighttime sleep (8, 9) . So far, it is completely unknown whether counterregulation as well as awakening upon hypoglycemia differs between the early and late part of nocturnal sleep in normal or pathological conditions. Clinically, this question is particular important since several studies have reported that approximately 60 to 70 % of nocturnal hypoglycemic episodes in type 1 diabetes patients occur during late sleep, i.e., between 3:00 and 7:00 h (10) (11) (12) (13) (14) .
RESEARCH DESIGN AND METHODS
Sixteen healthy subjects (men/women: 8/8; BMI 23.0 ± 0.6 kg/m 2 ; age 28.4 ± 1.5 years) were studied. All subjects had a regular sleep-wake cycle during the four weeks before the experiments and had not worked on night shifts. The study was approved by the Ethics Committee of the University of Lübeck. All subjects gave written informed consent.
Following an adaptation night in the laboratory, each subject was tested on 3 experimental nights that were spaced at least 2 weeks apart and included standard polysomnography (see Appendix 1). On two nights hypoglycemia was induced by intravenous insulin infusion; once the infusion started soon after sleep onset at the first occurrence of stage 2 sleep (early hypoglycemia) and another time after subjects had slept for about 3.5 hours (late hypoglycemia). In the control night no hypoglycemia was induced and also no insulin was infused. Experiments were performed in a single-blind fashion and the order of conditions was assigned according to a within-subject cross-over design.
Induction of hypoglycemia followed a standard protocol as previously described in detail (3) . The start of insulin infusion varied between 23:00 and 0:45 h in the early hypoglycemia night and between 2:45 and 3:30 h in the late hypoglycemia night, depending on the exact time the subject fell asleep. Plasma glucose was allowed to fall in a linear manner to a nadir of 2.2 mmol/l which was reached after 60 min. The temporal dynamics of decreasing glucose concentrations was controlled by simultaneous infusion of a 20% glucose solution whenever necessary. At the nadir concentration of 2.2 mmol/l insulin infusion was stopped and plasma glucose levels were brought back immediately into the normal range by glucose infusion. During the 60-min period of insulin infusion blood samples were collected every 5 min for determination of counterregulatory hormones. During the remaining night and in the control nights blood was sampled every 30 minutes. Blood sampling and infusions were carried out via long thin tubes (dead space: 1.5 ml) from an adjacent room without disturbing the subject's sleep. Determination of epinephrine, norepinephrine, ACTH, cortisol, growth hormone, and glucagon was performed as described in Appendix 2.
Statistical analysis.
All values are presented as means ± SEM. Analyses of variance (ANOVA) were performed on sleep data and on the changes in hormone levels during the hypoglycemic intervals (value end of interval -value before ) and during the corresponding control intervals. The ANOVA included the repeated measures factors `hypo` for differences between the hypoglycemic vs. control interval (in the control night) and `early/late` for differences between the early and late part of sleep. Additionally, hormonal concentrations during hypoglycemia were analyzed separately, which also accounted for the higher sampling rate during the hypoglycemic than control intervals. The respective ANOVA models included the repeated measures factors `early/late` for early vs. late night hypoglycemia and `time` for the repeated measurement of the hormones. To detect potential influences of gender and the order of experimental conditions respective factors were additionally included in the ANOVA models. However, since neither of these factors revealed any significant main or interaction effect, we report here only results from analyses not including the factors gender and order. Pearson correlation analyses were performed to detect potential associations between the extent of counterregulatory hormone responses and the amount of different sleep stages during the early and late hypoglycemic interval. Pair-wise comparison for continuous variables relied on Student's t-test and for categorized variables on the McNemar test. A P-value < 0.05 was considered significant.
RESULTS
Prior to the infusion of insulin plasma glucose concentration was slightly higher during the early than late hypoglycemic night (5.8 ± 0.3 mmol/l vs. 5.1 ± 0.2 mmol/l; P = 0.029). The hypoglycemic nadir concentration was identical in both conditions (2.23 ± 0.01 vs. 2.24 ± 0.02 mmol/l; P = 0.694). The rate of fall in glucose levels tended to be higher during the early than late hypoglycemia (0.057 ± 0.003 vs. 0.048 ± 0.003 mmol/l x min; P = 0.051; Fig. 1 ). There were no significant differences in serum insulin concentrations (1014 ± 120 vs. 875 ± 98 pmol/l; P = 0.602) and glucose infusion rates (21 ± 5 vs. 16 ± 8 ml/h; P = 0.257) during early or late hypoglycemia.
During early hypoglycemia awakening was observed in 10 of the 16 subjects, whereas during the corresponding time interval of the control night none of the subjects showed polysomnographical signs of awakening (P = 0.004). During the late sleep hypoglycemia all subjects awakened, whereas during the corresponding time in the control night spontaneous awakening occurred in 4 of the 16 subjects (P < 0.001). The effect on awakenings caused by hypoglycemia was comparable for early and late sleep, because awakenings generally occurred more often during late than early sleep in both the hypoglycemia and the control condition (χ² = 0.53, P > 0.45 by hierarchical log linear analysis). Interestingly, none of the subjects awoke from REM sleep. The plasma glucose concentrations at which the subjects awakened were very similar for both hypoglycemic conditions, ranging between 2.2 and 2.7 mmol/l (mean ± SEM 2.33 ± 0.05 mmol/l) during early hypoglycemia and between 2.2 and 2.7 mmol/l (2.28 ± 0.05 mmol/l) during late hypoglycemia. Table 1 summarizes the percent of time spent awake and in the different sleep stages during a 70-min interval comprising the 60 minutes of insulin infusion and the succeeding 10 min, for the early and late hypoglycemic nights as well as for corresponding time intervals in the control night. Overall, hypoglycemia in comparison to the control night intervals was associated with an increased time spent awake (P < 0.001) with this association not depending on whether hypoglycemia was induced during early or late sleep (P = 0.717).
Analyses of the changes in counterregulatory hormone levels during the hypoglycemic and corresponding control night intervals revealed that, except of glucagon, all counterregulatory hormones increased during hypoglycemia with the rise in epinephrine, ACTH, and cortisol more pronounced during the early than late hypoglycemia (all P < 0.05; Table 2 ). It should be noted that although peak cortisol levels were similar after the early and late hypoglycemia, this peak level only during early sleep reflects an exclusive response to hypoglycemia. During late sleep, levels also increased during the control interval which indicates that the increase in cortisol upon late hypoglycemia was partly due to the normal circadian rise in cortisol concentration at this time (Table 2) .
Separate analyses of the time course of hormonal counterregulation during the two hypoglycemic intervals revealed similar results indicating a greater increase in epinephrine, norepinephrine, ACTH, cortisol, and also in growth hormone concentrations during the early than late hypoglycemia (all P < 0.05; Fig. 2 ). ANOVA performed on plasma glucagon levels revealed a significant effect of 'time' (P = 0.043) indicating an acute decrease in glucagon concentrations in the beginning of the hypoglycemic period which was followed by a slight increase. However, although glucagon levels tended to be generally higher during the early than late hypoglycemia (P = 0.074) there was no difference in the temporal course of glucagon concentrations between the two hypoglycemic conditions (P = 0.498).
Inspection of individual time courses of plasma epinephrine concentrations revealed that a clear-cut rise in concentrations, exceeding 100 % within 5 min, was observed in 12 subjects during early hypoglycemia and also in 12 subjects during late hypoglycemia with 9 subjects showing an increase during both early and late hypoglycemia. Thus, despite the smaller size of the counterregulatory epinephrine response during late sleep, the number of subjects showing an activation of this neuroendocrine system was not reduced in this late period of sleep. The plasma glucose level at which epinephrine levels started to rise, i.e. the glycemic threshold, was identical during early and late hypoglycemia (2.57 ± 0.14 vs. 2.53 ± 0.09 mmol/l; P = 0.98). In all cases, epinephrine levels increased before awakening. However, the time interval between the onset of the epinephrine response and awakening was shorter during early than late hypoglycemia (5.6 ± 1.7 vs. 10.7 ± 2.9 min; P = 0.050). Correlation analyses did not reveal any significant association between the amplitude (value end of interval -value before ) of counterregulatory hormone responses and the time spent in the different sleep stages during the early and late hypoglycemic interval (all P > 0.15).
DISCUSSION
Our data show that in healthy subjects hormonal counterregulatory responses to hypoglycemia are distinctly weaker during the late than early part of nocturnal sleep. While hormonal counterregulation was diminished during late sleep, the arousing effects of hypoglycemia were maintained, because the rate of awakenings induced by hypoglycemia during early and late sleep was almost identical.
Based on our data it cannot be decided whether the decrease in hormonal counterregulation to hypoglycemia during late sleep is an immediate consequence of sleep or caused by circadian oscillators. Previous studies (2,4,5) comparing effects of hypoglycemia during early nocturnal periods of sleep and wakefulness showed that the suppressed hormonal responsiveness to hypoglycemia during early sleep is indeed caused by sleep-dependent mechanisms. Also, hormonal systems involved in hypoglycemia counterregulation (i.e., release of epinephrine and cortisol) are suppressed during REM sleep that predominates late sleep (9, 15, 16) . This could well explain the even more pronounced decrease in hormonal counterregulation observed here during the late phase of nocturnal sleep, although it does not rule out contributions of circadian factors.
Several limitations of the present study need to be mentioned. First, since no hyperinsulinemic-euglycemic clamps were performed during the control night we cannot fully exclude that the increased number of awakening during hypoglycemia was facilitated by concurrent hyperinsulinemia.
However, previous studies using different modes of insulin and glucose administration have provided evidence that hyperinsulinemia per se does not substantially affect sleep (e.g. 17, 18) . Second, the higher frequency of blood sampling during the hypoglycemic intervals as compared with control intervals could have confounded awakening responses (19) . However, blood sampling from an adjacent room was normally not noticed by the subject even when awake. Finally, the rate of fall in glucose levels tended to be higher during early than late hypoglycemia which may have contributed to the stronger neuroendocrine counterregulatory responses during early sleep.
In light of evidence of an increased frequency of hypoglycemic episodes during late sleep, our finding is of particular clinical relevance. However, it must be pointed out that the present results were obtained in healthy subjects and therefore, cannot be directly generalized to patients with diabetes. It will hence be of utmost importance to explore whether similar differences in hormonal counterregulation between early and late nocturnal hypoglycemia likewise exist in diabetic patients.
Figure legends
FIG. 1. Mean ± SEM plasma glucose concentrations during the 60 min of insulin infusion in the early hypoglycemia condition (black circles) and in the late hypoglycemia condition (white circles). Insulin infusion started on average at 23:36 h ± 7 min during early hypoglycemia and at 03:04 h ± 3 min during late hypoglycemia.
FIG. 2.
Mean ± SEM concentrations of counterregulatory hormones during the 60 min of insulin infusion in the early (left, black circles) and late (right, black triangles) hypoglycemia nights and during the corresponding time interval in the control night, in which no hypoglycemia was induced (empty circles and triangles, respectively). 
